Bryan A. Ward
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Virology top 2%
- HIV Research and Treatment
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Inflammatory mediators and NSAID effects 2
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Zeruesenay Desta (7 shared papers)David A. Flockhart (6 shared papers)Nadia Soukhova (1 shared paper)David R. Jones (2 shared papers)Stephen D. Hall (1 shared paper)J. Christopher Gorski (1 shared paper)Lang Li (1 shared paper)Kathrin Klein (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)American Journal of Tropical Medicine and Hygiene (1 paper)Pharmacogenomics (1 paper)Journal of Chromatography B (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Bryan A. Ward
8 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Pharmacology 677
- Virology 252
- Infectious Diseases 450
- Oncology 392
- Genetics 392
Countries citing papers authored by Bryan A. Ward
This map shows the geographic impact of Bryan A. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan A. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan A. Ward more than expected).
Fields of papers citing papers by Bryan A. Ward
This network shows the impact of papers produced by Bryan A. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan A. Ward. The network helps show where Bryan A. Ward may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan A. Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity Hit paper breakdown → | 2003 | 502 |
| 2 | 2004 | 492 | |
| 3 | 2007 | 183 | |
| 4 | 2003 | 80 | |
| 5 | 2010 | 60 | |
| 6 | 2004 | 44 | |
| 7 | 1971 | 28 | |
| 8 | Diindolylmethane inhibits indoleamine 2,3-dioxygenase activity in breast cancer cells | 2005 | 1 |
About Bryan A. Ward
Bryan A. Ward is a scholar working on Pharmacology, Infectious Diseases, Genetics, Pharmacology and Virology, having authored 8 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Estrogen and related hormone effects (3 papers), HIV Research and Treatment (2 papers), HIV/AIDS drug development and treatment (2 papers), Inflammatory mediators and NSAID effects (2 papers), Tryptophan and brain disorders (1 paper), Cancer Treatment and Pharmacology (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Pharmacology (677 citations), Virology (252 citations), Infectious Diseases (450 citations), Oncology (392 citations) and Genetics (392 citations). Bryan A. Ward has collaborated with scholars based in United States and Germany. Frequent co-authors include Zeruesenay Desta, David A. Flockhart, Nadia Soukhova, David R. Jones, Stephen D. Hall, J. Christopher Gorski, Lang Li, Kathrin Klein, Julia Blievernicht and Tanja Saußele. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Pharmacology and Experimental Therapeutics, American Journal of Tropical Medicine and Hygiene, Pharmacogenomics and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.